The mutation has been found to play a key role in a variety of cancers, including colorectal cancer (the third leading cause of cancer deaths worldwide), melanoma, papillary thyroid cancer, and hairy cell leukemia.
Read More
Ultra-sensitive detection of minimal residual disease now available to more people with blood cancers.
Read More
Reimbursement looms as major challenge
Read More
The test has been shown to offer sensitivity for the detection of residual cancer cells in marrow or blood.
Read More
As the potential use and benefit of next-gen sequencing becomes more evident, the arrival of this emerging technology and the resulting paradigm shift seem imminent.
Read More